Jerzy Gruhn
Corporate Officer/Principal bei European Association For The Study of Diabetes
Profil
Jerzy Gruhn is a member of the European Association For The Study of Diabetes.
He previously worked as a Director at Pharmaceutical Research & Manufacturers of America, Senior Vice President & Head-Europe Region at Novo Nordisk A, and President at Novo Nordisk, Inc. He graduated from the University of Warsaw in 1990.
Aktive Positionen von Jerzy Gruhn
| Unternehmen | Position | Beginn |
|---|---|---|
| European Association For The Study of Diabetes | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jerzy Gruhn
| Unternehmen | Position | Ende |
|---|---|---|
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Präsident | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Direktor/Vorstandsmitglied | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Ausbildung von Jerzy Gruhn
| University of Warsaw | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| European Association For The Study of Diabetes | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
